89 related articles for article (PubMed ID: 20358441)
1. A comparison of several methods for analyzing data from thorough QT studies.
Tian H; Qiao W; Natarajan J
J Biopharm Stat; 2010 May; 20(3):632-40. PubMed ID: 20358441
[TBL] [Abstract][Full Text] [Related]
2. Sample size and power estimation in "thorough" QT/QTc studies with parallel group design.
Hosmane B; Locke C; Chiu YL
J Biopharm Stat; 2010 May; 20(3):578-86. PubMed ID: 20358437
[TBL] [Abstract][Full Text] [Related]
3. Exposure-response modeling approach for assessing QT effect in "thorough" QT/QTc studies.
Hosmane B; Locke C; Chiu YL
J Biopharm Stat; 2010 May; 20(3):615-31. PubMed ID: 20358440
[TBL] [Abstract][Full Text] [Related]
4. Sample size calculations for crossover thorough QT studies: satisfaction of regulatory threshold and assay sensitivity.
Anand SP; Murray SC; Koch GG
J Biopharm Stat; 2010 May; 20(3):587-603. PubMed ID: 20358438
[TBL] [Abstract][Full Text] [Related]
5. Multiple comparisons of repeatedly measured response: issues of validation testing in thorough QT/QTc clinical trials.
Tsong Y; Yan LK; Zhong J; Nie L; Zhang J
J Biopharm Stat; 2010 May; 20(3):654-64. PubMed ID: 20358443
[TBL] [Abstract][Full Text] [Related]
6. Sample size calculation for thorough QT/QTc study considering various factors related to multiple time points.
Meng Z; Kringle R; Chen X; Zhao PL
J Biopharm Stat; 2010 May; 20(3):563-77. PubMed ID: 20358436
[TBL] [Abstract][Full Text] [Related]
7. Statistical consideration in testing for assay sensitivity in a "thorough" QT study.
Sethuraman V; Wu S; Wang J
J Biopharm Stat; 2010 May; 20(3):641-53. PubMed ID: 20358442
[TBL] [Abstract][Full Text] [Related]
8. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.
Meng Z; Quan H; Fan L; Kringle R; Sun G
J Biopharm Stat; 2010 May; 20(3):665-82. PubMed ID: 20358444
[TBL] [Abstract][Full Text] [Related]
9. Multiple comparisons of repeated measured response: issues of assessment of prolongation of QT interval in thorough QT trials.
Tsong Y; Zhong J
J Biopharm Stat; 2010 May; 20(3):604-14. PubMed ID: 20358439
[TBL] [Abstract][Full Text] [Related]
10. A nonparametric approach to QT interval correction for heart rate.
Wang D; Cheung YB; Arezina R; Taubel J; Camm AJ
J Biopharm Stat; 2010 May; 20(3):508-22. PubMed ID: 20358433
[TBL] [Abstract][Full Text] [Related]
11. A Bayesian measurement error approach to QT interval correction and prolongation.
Chen J; Zhao X
J Biopharm Stat; 2010 May; 20(3):523-42. PubMed ID: 20358434
[TBL] [Abstract][Full Text] [Related]
12. Further discussion on the design and analysis of thorough QTc clinical trials: guest editors' notes.
Tsong Y; Zhang J
J Biopharm Stat; 2010 May; 20(3):493-6. PubMed ID: 20358431
[No Abstract] [Full Text] [Related]
13. Performance characteristics for some typical QT study designs under the ICH E-14 guidance.
Hutmacher MM; Chapel S; Agin MA; Fleishaker JC; Lalonde RL
J Clin Pharmacol; 2008 Feb; 48(2):215-24. PubMed ID: 18199896
[TBL] [Abstract][Full Text] [Related]
14. Statistical characterization of QT prolongation.
Schall R; Ring A
J Biopharm Stat; 2010 May; 20(3):543-62. PubMed ID: 20358435
[TBL] [Abstract][Full Text] [Related]
15. Mixed models for data from thorough QT studies: part 1. assessment of marginal QT prolongation.
Schall R; Ring A
Pharm Stat; 2011; 10(3):265-76. PubMed ID: 21574242
[TBL] [Abstract][Full Text] [Related]
16. Impact of baseline ECG collection on the planning, analysis and interpretation of 'thorough' QT trials.
Sethuraman V; Sun Q
Pharm Stat; 2009; 8(2):113-24. PubMed ID: 18481273
[TBL] [Abstract][Full Text] [Related]
17. Statistical models for heart rate correction of the QT interval.
Ring A
Stat Med; 2010 Mar; 29(7-8):786-96. PubMed ID: 20213712
[TBL] [Abstract][Full Text] [Related]
18. Revisit the combination validation test of Tsong et al. for thorough QT/QTc clinical trials.
Sun GG; Quan H
J Biopharm Stat; 2010 May; 20(3):683-7; author reply 688. PubMed ID: 20358445
[No Abstract] [Full Text] [Related]
19. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
20. Assessing equivalence of two assays using sensitivity and specificity.
Quiroz J; Burdick RK
J Biopharm Stat; 2007; 17(3):433-43. PubMed ID: 17479392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
